von Mucke-Heim I, Oldekamp J, Metzger M, Klaffgen S, Tang H, Walser S
Purinergic Signal. 2025; .
PMID: 40024982
DOI: 10.1007/s11302-025-10074-x.
Weiss F, Alvarez Y, Shakeri F, Sahu A, Leka P, Dernst A
Cell Death Differ. 2024; 31(12):1717-1729.
PMID: 39289506
PMC: 11618613.
DOI: 10.1038/s41418-024-01379-2.
Uzay B, Donmez-Demir B, Ozcan S, Kocak E, Yemisci M, Gursoy Ozdemir Y
J Headache Pain. 2024; 25(1):120.
PMID: 39044141
PMC: 11267761.
DOI: 10.1186/s10194-024-01807-1.
Yuan C, Liu L, Zhao Y, Wang K
J Cell Mol Med. 2024; 28(14):e18550.
PMID: 39042561
PMC: 11265464.
DOI: 10.1111/jcmm.18550.
Sierra-Marquez J, Schaller L, Sassenbach L, Ramirez-Fernandez A, Alt P, Rissiek B
Front Immunol. 2024; 15:1425938.
PMID: 38953020
PMC: 11215518.
DOI: 10.3389/fimmu.2024.1425938.
Time-resolved role of P2X4 and P2X7 during CD8 T cell activation.
Brock V, Lory N, Mockl F, Birus M, Stahler T, Woelk L
Front Immunol. 2024; 15:1258119.
PMID: 38426095
PMC: 10902106.
DOI: 10.3389/fimmu.2024.1258119.
SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cells.
Iida H, Kono T, Lee C, Krishnan P, Arvin M, Weaver S
Diabetologia. 2023; 66(11):2042-2061.
PMID: 37537395
PMC: 10542743.
DOI: 10.1007/s00125-023-05979-4.
Transcriptomic analysis reveals novel age-independent immunomodulatory proteins as a mode of cerebroprotection in P2X4 receptor knockout mice after ischemic stroke.
Gamiotea-Turro D, Cronin C, Liang B, Verma R
Purinergic Signal. 2023; 19(3):489-500.
PMID: 37439999
PMC: 10539265.
DOI: 10.1007/s11302-023-09956-9.
Animal Models for the Investigation of P2X7 Receptors.
Sluyter R, Adriouch S, Fuller S, Nicke A, Sophocleous R, Watson D
Int J Mol Sci. 2023; 24(9).
PMID: 37175933
PMC: 10179175.
DOI: 10.3390/ijms24098225.
Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer's disease.
Hua J, de Paco E, Linck N, Maurice T, Desrumaux C, Manoury B
Cell Mol Life Sci. 2023; 80(5):138.
PMID: 37145189
PMC: 10163120.
DOI: 10.1007/s00018-023-04784-x.
The role of the ATP-adenosine axis in ischemic stroke.
Schadlich I, Winzer R, Stabernack J, Tolosa E, Magnus T, Rissiek B
Semin Immunopathol. 2023; 45(3):347-365.
PMID: 36917241
PMC: 10279578.
DOI: 10.1007/s00281-023-00987-3.
Real-Time Flow Cytometry as a Tool to Monitor Cellular Consequences of P2X7 Activation in Multiple Cell Populations Mixed in a Single FACS Tube.
Veltkamp A, Magnus T, Rissiek B
Methods Mol Biol. 2022; 2510:291-302.
PMID: 35776332
DOI: 10.1007/978-1-0716-2384-8_16.
Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer's Disease.
Castillo C, Saez-Orellana F, Godoy P, Fuentealba J
Front Physiol. 2022; 13:814999.
PMID: 35283778
PMC: 8904919.
DOI: 10.3389/fphys.2022.814999.
P2X4 and P2X7 are essential players in basal T cell activity and Ca signaling milliseconds after T cell activation.
Brock V, Wolf I, Er-Lukowiak M, Lory N, Stahler T, Woelk L
Sci Adv. 2022; 8(5):eabl9770.
PMID: 35119925
PMC: 8816335.
DOI: 10.1126/sciadv.abl9770.
Identification of the Mouse T Cell ADP-Ribosylome Uncovers ARTC2.2 Mediated Regulation of CD73 by ADP-Ribosylation.
Leutert M, Duan Y, Winzer R, Menzel S, Tolosa E, Magnus T
Front Immunol. 2021; 12:703719.
PMID: 34504490
PMC: 8421852.
DOI: 10.3389/fimmu.2021.703719.
Bone phenotype of P2X4 receptor knockout mice: implication of a P2X7 receptor mutation?.
Ellegaard M, Hegner T, Ding M, Ulmann L, Jorgensen N
Purinergic Signal. 2021; 17(2):241-246.
PMID: 33856623
PMC: 8155156.
DOI: 10.1007/s11302-021-09784-9.
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.
Illes P, Muller C, Jacobson K, Grutter T, Nicke A, Fountain S
Br J Pharmacol. 2020; 178(3):489-514.
PMID: 33125712
PMC: 8199792.
DOI: 10.1111/bph.15299.